EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Pomegranate‐Derived Nanovesicles Exert Therapeutic Effects by Modulating Inflammatory Responses in a Murine Model of Chronic Dermatitis

Miquel Martínez‐Navarrete, Christian Sánchez‐López, Antonio José Guillot García, M. Carmen Recio, Rosa M. Giner, Antonio Marcilla, Ana Melero

Journal of Extracellular Vesicles · 2026-11 · 15 (11)

DOI: 10.1002/jev2.70403 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Extracellular vesicles are gaining attention in the pharmaceutical field due to their potential as therapeutic and delivery platforms. Among these, plant nanovesicles (PNVs) are particularly promising due to their reported biological activity. Pomegranate ( Punica granatum ) has been widely used in traditional medicine for its antioxidant and anti‐inflammatory properties. Recent studies have revealed that pomegranate juice contains PNVs with therapeutic potential. In this study, pomegranate‐derived nanovesicles ( Pg NVs) were isolated, characterized, and pharmacologically evaluated in dermatitis‐like in vivo murine models of delayed‐type hypersensitivity (DTH) and chronic dermatitis. Subcutaneous administration of Pg NVs modulated pro‐inflammatory cytokine expression, particularly by reducing IL‐4 and IL‐1β levels in the DTH model. Moreover, in the chronic dermatitis model, Pg NVs‐treated mice exhibited reduced histopathological skin damage, decreasing epidermal hyperplasia, collagen deposition, and immune cell infiltration. Additionally, Pg NVs enhanced the secretion of the anti‐inflammatory cytokine IL‐10, while decreasing the levels of pro‐inflammatory mediators like IL‐1β. Importantly, the long‐term effects of Pg NVs treatment were compared to those of topical corticosteroids (TCS), which constitute the current standard treatment for dermatitis. Unlike TCS, Pg NVs did not induce side effects. Overall, these findings support the therapeutic potential of Pg NVs as a promising, safe and sustainable alternative approach to treat chronic inflammatory skin diseases.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →